Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Wyman, B.T.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(5)
+
-
Availability
Metadata Only
(5)
+
-
Creation Date
2015
(2)
+
-
Faculty
Faculty of Social and Behavioural Sciences
(1)
+
-
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Topic
FMRI
(2)
+
-
Functional connectivity
(2)
+
-
Neuropharmacology
(2)
+
-
Resting state networks
(2)
+
-
SSRI
(2)
+
-
Serotonin
(2)
+
-
Show more
Author
Wyman, B.T.
(5)
+
-
Bradley, J.D.
(3)
+
-
Heijde, D. van der
(3)
+
-
Conaghan, P.G.
(2)
+
-
Hrycaj, P.
(2)
+
-
Irazoque-Palazuelos, F.
(2)
+
-
Khalili-Mahani, N.
(2)
+
-
Klaassens, B.L.
(2)
+
-
Ostergaard, M.
(2)
+
-
Rombouts, S.A.R.B.
(2)
+
-
Soma, K.
(2)
+
-
Whitcher, B.
(2)
+
-
Wilkinson, B.
(2)
+
-
Zhang, R.
(2)
+
-
Show more
Language
en
(5)
+
-
Search results
(1 - 5 of 5)
show grid
show list
save search
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitati
Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity
Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity
Effects of Tofacitinib on Bone Marrow Edema, Synovitis, and Erosive Damage in Methotrexate-Naive Patients with Early Active Rheumatoid Arthritis (Duration <= 2 Years): Results of an Exploratory Phase 2 MRI Study
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study